Found: 133
Select item for more details and to access through your institution.
Effectiveness of the Original Monovalent Coronavirus Disease 2019 Vaccines in Preventing Emergency Department or Urgent Care Encounters and Hospitalizations Among Adults With Disabilities: VISION Network, June 2021-September 2022.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad474
- By:
- Publication type:
- Article
Hybrid Immunity and SARS-CoV-2 Antibodies: Results of the HEROES–RECOVER Prospective Cohort Study.
- Published in:
- Clinical Infectious Diseases, 2024, v. 79, n. 1, p. 96, doi. 10.1093/cid/ciae130
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 4, p. 1056, doi. 10.1093/cid/ciad677
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Pediatric Influenza-A–Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2022–2023 Season: VISION Network.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 3, p. 746, doi. 10.1093/cid/ciad704
- By:
- Publication type:
- Article
Clinical Epidemiology and Risk Factors for Critical Outcomes Among Vaccinated and Unvaccinated Adults Hospitalized With COVID-19—VISION Network, 10 States, June 2021–March 2023.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 338, doi. 10.1093/cid/ciad505
- By:
- Publication type:
- Article
Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021–August 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 4, p. 547, doi. 10.1093/cid/ciad276
- By:
- Publication type:
- Article
Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 11, p. 1980, doi. 10.1093/cid/ciad031
- By:
- Publication type:
- Article
Severe Acute Respiratory Syndrome Coronavirus 2 Infection History and Antibody Response to 3 Coronavirus Disease 2019 Messenger RNA Vaccine Doses.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 10, p. 1822, doi. 10.1093/cid/ciac976
- By:
- Publication type:
- Article
Relationships Between Social Vulnerability and Coronavirus Disease 2019 Vaccination Coverage and Vaccine Effectiveness.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 9, p. 1615, doi. 10.1093/cid/ciad003
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 8, p. 1358, doi. 10.1093/cid/ciac941
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza A(H3N2)–Associated Hospitalized Illness: United States, 2022.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 6, p. 1030, doi. 10.1093/cid/ciac869
- By:
- Publication type:
- Article
Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18–64 Years: A Randomized, Open-Label Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e1168, doi. 10.1093/cid/ciac683
- By:
- Publication type:
- Article
Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States.
- Published in:
- Clinical Infectious Diseases, 2023, v. 76, n. 3, p. e460, doi. 10.1093/cid/ciac381
- By:
- Publication type:
- Article
Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S271, doi. 10.1093/cid/ciac472
- By:
- Publication type:
- Article
Effectiveness of the Ad26.COV2.S (Johnson & Johnson) Coronavirus Disease 2019 (COVID-19) Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, p. S159, doi. 10.1093/cid/ciac439
- By:
- Publication type:
- Article
Neutralizing Antibody Response to Pseudotype Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Differs Between mRNA-1273 and BNT162b2 Coronavirus Disease 2019 (COVID-19) Vaccines and by History of SARS-CoV-2 Infection.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e827, doi. 10.1093/cid/ciab1038
- By:
- Publication type:
- Article
Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccines for Preventing Coronavirus Disease 2019 Hospitalizations in the United States.
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 9, p. 1515, doi. 10.1093/cid/ciab687
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015–2016 to 2017–2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
- Published in:
- Clinical Infectious Diseases, 2022, v. 74, n. 8, p. 1329, doi. 10.1093/cid/ciab654
- By:
- Publication type:
- Article
Coronavirus disease 2019 (COVID-19) Versus Influenza in Hospitalized Adult Patients in the United States: Differences in Demographic and Severity Indicators.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 12, p. 2240, doi. 10.1093/cid/ciab123
- By:
- Publication type:
- Article
Effectiveness of Influenza Vaccine for Preventing Laboratory-Confirmed Influenza Hospitalizations in Immunocompromised Adults.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4353, doi. 10.1093/cid/ciaa1927
- By:
- Publication type:
- Article
Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States—2019–2020.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4244, doi. 10.1093/cid/ciaa1884
- By:
- Publication type:
- Article
Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015–2016 to 2018–2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 4, p. 726, doi. 10.1093/cid/ciab045
- By:
- Publication type:
- Article
Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012–2013 Through 2017–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 497, doi. 10.1093/cid/ciaa706
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in Inpatient and Outpatient Settings in the United States, 2015–2018.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 3, p. 386, doi. 10.1093/cid/ciaa407
- By:
- Publication type:
- Article
Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory Illness.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. e426, doi. 10.1093/cid/ciaa1023
- By:
- Publication type:
- Article
Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011–2012 to 2016–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 7, p. 1147, doi. 10.1093/cid/ciaa102
- By:
- Publication type:
- Article
Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults—United States, 2015–2017.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 6, p. 995, doi. 10.1093/cid/ciaa160
- By:
- Publication type:
- Article
Reply to Yager and Doll.
- Published in:
- 2020
- By:
- Publication type:
- Letter to the Editor
Reducing Antibiotic Use in Ambulatory Care Through Influenza Vaccination.
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 11, p. e726, doi. 10.1093/cid/ciaa464
- By:
- Publication type:
- Article
Effects of Influenza Vaccination in the United States During the 2017–2018 Influenza Season.
- Published in:
- Clinical Infectious Diseases, 2019, v. 69, n. 11, p. 1845, doi. 10.1093/cid/ciz075
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 11, p. 1798, doi. 10.1093/cid/ciy775
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness and Statin Use Among Adults in the United States, 2011–2017.
- Published in:
- Clinical Infectious Diseases, 2019, v. 68, n. 10, p. 1616, doi. 10.1093/cid/ciy780
- By:
- Publication type:
- Article
Influenza Antiviral Prescribing for Outpatients With an Acute Respiratory Illness and at High Risk for Influenza-Associated Complications During 5 Influenza Seasons--United States, 2011-2016.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 7, p. 1035, doi. 10.1093/cid/cix922
- By:
- Publication type:
- Article
2015-2016 Vaccine Effectiveness of Live Attenuated and Inactivated Influenza Vaccines in Children in the United States.
- Published in:
- Clinical Infectious Diseases, 2018, v. 66, n. 5, p. 665, doi. 10.1093/cid/cix869
- By:
- Publication type:
- Article
Anti–SARS-CoV-2 Antibody Levels Associated With COVID-19 Protection in Outpatients Tested for SARS-CoV-2, US Flu Vaccine Effectiveness Network, October 2021–June 2022.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 45, doi. 10.1093/infdis/jiae090
- By:
- Publication type:
- Article
Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023.
- Published in:
- Journal of Infectious Diseases, 2024, v. 230, n. 1, p. 141, doi. 10.1093/infdis/jiad542
- By:
- Publication type:
- Article
Total and Subgenomic RNA Viral Load in Patients Infected With SARS-CoV-2 Alpha, Delta, and Omicron Variants.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 3, p. 235, doi. 10.1093/infdis/jiad061
- By:
- Publication type:
- Article
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network.
- Published in:
- Journal of Infectious Diseases, 2023, v. 228, n. 2, p. 185, doi. 10.1093/infdis/jiad015
- By:
- Publication type:
- Article
Protection From COVID-19 mRNA Vaccination and Prior SARS-CoV-2 Infection Against COVID-19–Associated Encounters in Adults During Delta and Omicron Predominance.
- Published in:
- Journal of Infectious Diseases, 2023, v. 227, n. 12, p. 1348, doi. 10.1093/infdis/jiad040
- By:
- Publication type:
- Article
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
- Published in:
- Journal of Infectious Diseases, 2022, v. 226, n. 5, p. 797, doi. 10.1093/infdis/jiac118
- By:
- Publication type:
- Article
Effectiveness of mRNA Vaccines Against COVID-19 Hospitalization by Age and Chronic Medical Conditions Burden Among Immunocompetent US Adults, March-August 2021.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 10, p. 1694, doi. 10.1093/infdis/jiab619
- By:
- Publication type:
- Article
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Influenza Vaccine Effectiveness Against Hospitalization in the United States, 2019-2020.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2018-2019, US Hospitalized Adult Influenza Vaccine Effectiveness Network.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Low Influenza Vaccine Effectiveness Against A(H3N2)-Associated Hospitalizations in 2016-2017 and 2017-2018 of the Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period.
- Published in:
- BMC Infectious Diseases, 2024, p. 1, doi. 10.1186/s12879-024-09108-3
- By:
- Publication type:
- Article
Severity of Respiratory Syncytial Virus vs COVID-19 and Influenza Among Hospitalized US Adults.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e244954, doi. 10.1001/jamanetworkopen.2024.4954
- By:
- Publication type:
- Article
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period -- IVY Network, 19 U.S. States, February 1, 2022-January 31, 2023
- Published in:
- MMWR Supplements, 2023, v. 72, n. 1, p. 463
- By:
- Publication type:
- Article
Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018–2022.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 12, p. 2442, doi. 10.3201/eid2912.231070
- By:
- Publication type:
- Article
Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers.
- Published in:
- Emerging Infectious Diseases, 2023, v. 29, n. 3, p. 599, doi. 10.3201/eid2903.221314
- By:
- Publication type:
- Article